SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and upcoming lung cancer data, following a strong performance at recent healthcare conferences. Community sentiment remains largely bullish, with investors focusing on the company's clear path to profitability and potential for long-term institutional accumulation.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is receiving attention following positive analyst coverage from Wells Fargo, which initiated the stock with an Overweight rating and a bullish price target. While some traders express ongoing frustration regarding the company's communication and macro-related volatility, others highlight the company's significant contracted backlog and data center expansion as strong long-term fundamentals.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is debating the market's aggressive overnight recovery following the Federal Reserve's rate hike, with many traders framing the price action as a "bear trap" or orchestrated liquidity event. While some investors interpret the rally as a sign of underlying economic strength and potential de-escalation in geopolitical tensions, others remain skeptical, citing persistent inflation, rising bond yields, and concerns that the move is an unsustainable short squeeze.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following an initiation of coverage with an Overweight rating from Wells Fargo, which has bolstered positive sentiment alongside ongoing insider buying from directors. While market volatility continues, investors are focused on the company's power infrastructure capabilities and its capacity to meet the growing demands of AI and high-performance computing.

Talon Metals Corp. engages in the exploration and development of mineral properties. It holds interests in the Tamarack nickel-copper-cobalt and Trairão iron projects. The company was founded on April 5, 2005 and is headquartered in Road Town, British Virgin Islands.

Talon Metals Corp

Talon Metals is experiencing a downward price trend and volatility driven by broader market uncertainty, including interest rate concerns and geopolitical tensions. Despite this, investors remain focused on the company's long-term potential, specifically the ongoing development of the Tamarack project and the recent selection of the Humboldt Mill as the processing hub for its operations.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing increased attention driven by its role in the emerging AI-crypto narrative, with traders highlighting its infrastructure for AI agents and cross-chain execution capabilities. Community sentiment is mixed, as some investors express confidence in long-term fundamental developments like protocol upgrades and fee-capture mechanisms, while others remain focused on short-term technical trading and broader market uncertainty.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors react to the company's participation in upcoming healthcare conferences, with speculation centering on potential oncology-related licensing agreements and the expansion of the Matrix-M adjuvant platform. While the stock has seen increased retail interest and volume, sentiment remains divided between optimism over long-term partnerships and frustration regarding the pace of material news and company leadership.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending as investors focus on upcoming clinical trial data readouts and the progress of its BLA submission for its lead CAR T-cell therapy, miv-cel. Community discussion is characterized by high conviction in the company's differentiated safety profile and potential for acquisition, with many traders debating valuation compared to peers despite ongoing market volatility.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

Traders are intensely debating the validity of circulating rumors alleging a pending buyout or merger involving Nvidia, with many community members dismissing the claims as fabricated due to lack of verified reporting and recent financial disclosures. While some bulls remain optimistic about the company's long-term potential and potential for a short squeeze, others are expressing frustration over the persistent decline in share price and lack of communication from management.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The community is closely tracking the company's potential for upcoming catalysts, including clinical trial updates for non-small cell lung cancer (NSCLC) and regulatory progress following a new patent publication related to Anktiva. Investor sentiment remains largely bullish, focusing on the company's immunotherapy platform and ongoing interest from billionaire investor Patrick Soon-Shiong, while some traders express frustration with price volatility and the pace of news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INTC, SKHY Stocks Jump Overnight: Intel’s Delayed Ohio Megafab Could Make SK Hynix’s First US Memory Chips 

$INTC $SKHY $SOXX $SOXS $RAM

https://stocktwits.com/news/equity/markets/intc-skhy-stocks-intel-delayed-ohio-megafab-sk-hynix-first-us-memory-chips/cZtYJ6ORB2i

Patrick Boyd

Options include leasing part of Intel's delayed Ohio campus or forming a venture with major cloud companies.

Stocktwits

INTC, SKHY Stocks Jump Overnight: Intel's Delayed Ohio Megafab Could Make SK Hynix's First US Memory Chips

$INTC I like the JV option way better. In this red hot memory chip market, imagine Intel to have the EARNING POWER of $AMD (Intel Product), $TSM (Intel Foundry) and $MU (JV) COMBINED. 

That&#39;s a 3 trillion dollar valuation for me!!!

StockTwits For Android 

Johnny Papa

StocktwitsNews

Intel Corp

SK Hynix Inc - ADR

iShares Semiconductor ETF

Direxion Daily Semiconductor Bear 3X ETF

T-REX 2X Long DRAM Daily Target ETF

INTC, SKHY Stocks Jump Overnight: Intel’s Delayed Ohio Megafab Could Make SK Hynix’s First US Memory Chips 



This account has been verified as an official STOCKTWITS representative.